Abstract
Proteins can undergo a variety of conformational changes upon ligand binding. Although different mechanisms may play a role, the phenomenon is commonly referred to as induced fit to indicate that the tight structural complementarity of the interaction partners is a consequence of the binding event. Docking methods need to take into account this ability of the ligand and the protein to mutually adapt to each other when forming a complex. Handling the ligand as flexible is already common practice in docking applications. This is not yet the case for the protein. In fact, the accurate prediction of protein conformational changes upon ligand binding is still a major challenge, even more if computational speed is an issue, as for example in virtual screening applications. However, significant progress has been made over the past years and many valuable approaches have become available to address the protein flexibility problem and to provide more reliable docking predictions for complexes governed by significant induced-fit effects. This review provides a brief overview of the current situation, the most recent advances, and the remaining limitations of flexible protein docking, with particular focus on approaches handling protein flexibility simultaneously with ligand placement in the docking process.
Keywords: Protein flexibility, conformational changes, induced fit, structure-based drug design, docking, scoring, protein-ligand complexes, ligand binding, NMR, PDB, enzymes, substrate binding, conformational selection, NADPH, cofactor, induced conformational change, 3D structures, RosettaLigand, flexibility, optimization, SLIDE, algorithms, ICM method, FlexX, GOLD, IFD, MRC docking, NMR data, DOCK, AutoDock, MD, FlexE, LMOD, domain, Gibbs free energy, entropic, enthalpic, AR, Leu300, Cys298-Leu300, X-ray crystallography, Trp20, Lys21, aldose reductase, TGT, MCM, ROSETTA, RMSD, SAMPL-1, JNK3, TAMD, MAP, ICM, MRC, EN NMA, SCARE, MADAMM, CHARMM, LGA, FITTED, CYP2D6, SOM, SA, FlexScreen, DUD, ChiFlex, CDOCKER, CDK2
Current Topics in Medicinal Chemistry
Title: Accounting for Induced-Fit Effects in Docking: What is Possible and What is Not?
Volume: 11 Issue: 2
Author(s): Christoph A. Sotriffer
Affiliation:
Keywords: Protein flexibility, conformational changes, induced fit, structure-based drug design, docking, scoring, protein-ligand complexes, ligand binding, NMR, PDB, enzymes, substrate binding, conformational selection, NADPH, cofactor, induced conformational change, 3D structures, RosettaLigand, flexibility, optimization, SLIDE, algorithms, ICM method, FlexX, GOLD, IFD, MRC docking, NMR data, DOCK, AutoDock, MD, FlexE, LMOD, domain, Gibbs free energy, entropic, enthalpic, AR, Leu300, Cys298-Leu300, X-ray crystallography, Trp20, Lys21, aldose reductase, TGT, MCM, ROSETTA, RMSD, SAMPL-1, JNK3, TAMD, MAP, ICM, MRC, EN NMA, SCARE, MADAMM, CHARMM, LGA, FITTED, CYP2D6, SOM, SA, FlexScreen, DUD, ChiFlex, CDOCKER, CDK2
Abstract: Proteins can undergo a variety of conformational changes upon ligand binding. Although different mechanisms may play a role, the phenomenon is commonly referred to as induced fit to indicate that the tight structural complementarity of the interaction partners is a consequence of the binding event. Docking methods need to take into account this ability of the ligand and the protein to mutually adapt to each other when forming a complex. Handling the ligand as flexible is already common practice in docking applications. This is not yet the case for the protein. In fact, the accurate prediction of protein conformational changes upon ligand binding is still a major challenge, even more if computational speed is an issue, as for example in virtual screening applications. However, significant progress has been made over the past years and many valuable approaches have become available to address the protein flexibility problem and to provide more reliable docking predictions for complexes governed by significant induced-fit effects. This review provides a brief overview of the current situation, the most recent advances, and the remaining limitations of flexible protein docking, with particular focus on approaches handling protein flexibility simultaneously with ligand placement in the docking process.
Export Options
About this article
Cite this article as:
A. Sotriffer Christoph, Accounting for Induced-Fit Effects in Docking: What is Possible and What is Not?, Current Topics in Medicinal Chemistry 2011; 11 (2) . https://dx.doi.org/10.2174/156802611794863544
DOI https://dx.doi.org/10.2174/156802611794863544 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
IGF-I Signaling in Response to Hyperglycemia and the Development of Diabetic Complications
Current Diabetes Reviews Effects of Synthetic Peptides on the Inflammatory Response and their Therapeutic Potential
Mini-Reviews in Medicinal Chemistry Commonalities in Biological Pathways, Genetics, and Cellular Mechanism between Alzheimer Disease and Other Neurodegenerative Diseases: An In Silico-Updated Overview
Current Alzheimer Research Targeted Vascular Drug Delivery in Cerebral Cancer
Current Pharmaceutical Design Inflammation in the CNS: Understanding Various Aspects of the Pathogenesis of Alzheimer's Disease
Current Alzheimer Research Factors Influencing Adherence Among Youth with Type-1-Diabetes Mellitus - The Hungarian Case
Current Diabetes Reviews Does Ceruloplasmin Defend Against Neurodegenerative Diseases?
Current Neuropharmacology Novel Non-Steroidal Anti-Inflammatory Drugs: What we have Learned from Animal Studies
Current Drug Targets - Inflammation & Allergy May Exercise Prevent Addiction?
Current Neuropharmacology Heavy Metal Toxicity in Humans and its Preventive and Control Measures
Current Nutrition & Food Science Drug Treatment of Obesity: Established and Emerging Therapies
Mini-Reviews in Medicinal Chemistry Potential Drugs and Methods for Preventing or Delaying the Progression of Huntington's Disease
Recent Patents on CNS Drug Discovery (Discontinued) Genetics of Alzheimer's Disease and Frontotemporal Dementia
Current Molecular Medicine Ring Finger Ubiquitin Protein Ligases and Their Implication to the Pathogenesis of Human Diseases
Current Pharmaceutical Design Phenanthridine Sulfonamide Derivatives as Potential DPP-IV Inhibitors: Design, Synthesis and Biological Evaluation
Current Computer-Aided Drug Design Synthesis and SAR Studies of Urea and Thiourea Derivatives of Gly/Pro Conjugated to Piperazine Analogue as Potential AGE Inhibitors
Protein & Peptide Letters Management of Glia-Mediated Neuroinflammation and Related Patents
Recent Patents on Inflammation & Allergy Drug Discovery Involvement of IL-1R/TLR Signalling in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
Current Molecular Medicine Oxidative-Nitrosative Stress as a Contributing Factor to Cardiovascular Disease in Subjects with Diabetes
Current Vascular Pharmacology Metabolic Syndrome, Mild Cognitive Impairment and Dementia
Current Alzheimer Research